GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (FRA:8VP1) » Definitions » Cyclically Adjusted Price-to-FCF

Avricore Health (FRA:8VP1) Cyclically Adjusted Price-to-FCF : (As of Dec. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avricore Health Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Avricore Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Avricore Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Cyclically Adjusted Price-to-FCF Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avricore Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avricore Health's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Avricore Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Avricore Health's Cyclically Adjusted Price-to-FCF falls into.



Avricore Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Avricore Health's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Avricore Health's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.001/127.2847*127.2847
=0.001

Current CPI (Sep. 2024) = 127.2847.

Avricore Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -0.032 98.367 -0.041
201503 -0.031 99.789 -0.040
201506 -0.017 100.500 -0.022
201509 -0.030 100.421 -0.038
201512 -0.020 99.947 -0.025
201603 -0.034 101.054 -0.043
201606 -0.026 102.002 -0.032
201609 -0.015 101.765 -0.019
201612 -0.020 101.449 -0.025
201703 0.004 102.634 0.005
201706 -0.025 103.029 -0.031
201709 -0.024 103.345 -0.030
201712 -0.016 103.345 -0.020
201803 -0.009 105.004 -0.011
201806 -0.014 105.557 -0.017
201809 -0.008 105.636 -0.010
201812 -0.004 105.399 -0.005
201903 -0.004 106.979 -0.005
201906 -0.002 107.690 -0.002
201909 -0.004 107.611 -0.005
201912 0.000 107.769 0.000
202003 -0.005 107.927 -0.006
202006 -0.003 108.401 -0.004
202009 -0.002 108.164 -0.002
202012 -0.003 108.559 -0.004
202103 -0.002 110.298 -0.002
202106 -0.003 111.720 -0.003
202109 -0.003 112.905 -0.003
202112 -0.002 113.774 -0.002
202203 -0.001 117.646 -0.001
202206 -0.003 120.806 -0.003
202209 -0.005 120.648 -0.005
202212 -0.003 120.964 -0.003
202303 -0.001 122.702 -0.001
202306 0.000 124.203 0.000
202309 -0.001 125.230 -0.001
202312 -0.001 125.072 -0.001
202403 0.002 126.258 0.002
202406 0.000 127.522 0.000
202409 0.001 127.285 0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avricore Health  (FRA:8VP1) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Avricore Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Avricore Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.

Avricore Health Headlines

No Headlines